← Latest news 
Thyrocare Q4 profit soars 128% to Rs 48.7 crore on scale and new diagnostics
Entertainment
Published on 7 May 2026
Profit jumps despite higher costs and new testing push
PharmEasy-owned Thyrocare Technologies reported a 128% year-on-year jump in Q4 FY26 consolidated net profit to Rs 48.7 crore, driven by operating leverage and volume growth. Revenue from operations rose 20% to Rs 224 crore. Tests processed surged 29% to 5.9 crore, while margins improved. The company also launched advanced allergy testing and entered genomics with NIPT.
- Q4 net profit rose 128% YoY to Rs 48.7 crore
- Revenue grew 20% YoY to Rs 224 crore, sequentially up 5%
- 5.9 crore tests processed, up 29% YoY; EBITDA margin improved
- New specialty tests and NIPT signal push into precision diagnostics
Read the full story at Inc42
This summarization was done by Beige for a story published on 
Inc42